TGFB1 and pneumonia: In acute pneumonia, an increase in TGF-β level reflects the activation of anti-inflammatory and regenerative mechanisms, as well as the differentiation of regulatory T cells, which makes TGF-β an important indicator of the effectiveness of immunocorrective therapy.